Venus Remedies Limited (NSE:VENUSREM)
India · Delayed Price · Currency is INR 1,445.50
-2.80 (-0.19%)
Nov 11, 2026, 1:39 PM IST
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 19.33 billion as of November 10, 2026. Its market cap has increased by 208.30% in one year.
Market Cap
19.33B
Enterprise Value
18.55B
Revenue
8.37B
Global Rank
n/a
Country Rank
n/a
PE Ratio
15.88
ChartMarket Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 19.33B, an increase of 7,861.03%. That is a compound annual growth rate of 21.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 19.33B | 88.56% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |
| Ind-Swift Laboratories | 30.35B |
| Sakar Healthcare | 22.89B |
| Indoco Remedies | 20.25B |
| Windlas Biotech | 20.10B |
| Beta Drugs | 19.07B |
| Jagsonpal Pharmaceuticals | 14.36B |